EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of gut microbiota in the neurobiology and treatment of Alzheimer’s disease

Seyed Khalil Rashidi, Mitra Ansari Dezfouli, Hamidreza Khalili, Ali Kiani Deh Kiani

General physiology and biophysics · 2026 · 45 (02) · 129-151

DOI: 10.4149/gpb_2025042 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift General physiology and biophysics, 2026. Verfasst von Seyed Khalil Rashidi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Hauptthemen laut MEDLINE: Alzheimer Disease, Gastrointestinal Microbiome, Brain.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is the most common cause of dementia in the elderly population and characterized by progressive cognitive decline. The major pathological features of AD are the accumulation of extracellular amyloid-beta protein as neuritic plaques and intracellular hyperphosphorylated tau protein as neurofibrillary tangles. Studies have shown that gut microbiota are involved in several central nervous system disorders through regulation of neurotransmitter production, blood-brain barrier permeability and immune responses. The gut microbiota establishes a two-way communication between the gut and the brain through neural, endocrine, and immune pathways, which play a role in various neurological diseases, including AD. Alterations in the composition and function of the gut microbiota may influence neuroinflammation, amyloid-beta accumulation, and tau pathology. Targeting the balance of the gut microbiota through probiotics, prebiotics, and fecal microbial transplantation could be promising therapeutic approach against neurodegeneration. Understanding the complex relationship between the gut microbiota and AD pathobiology could pave the way for novel preventive and therapeutic strategies. Here, we summarized advances in the role of gut microbiota in AD pathobiology and updated rising concerns from recent reports. Moreover, the possibility of applying the capability of the gut microbiota as a promising treatment against AD has been discussed in this review.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseGastrointestinal MicrobiomeBrainHumansAnimalsAmyloid beta-PeptidesProbioticsFecal Microbiota Transplantation

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Medical Biotechnology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Hearing Research Center, Clinical Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Department of Pharmacology, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Student Research and Technology Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Zitieren

APA

Rashidi, S. K., Dezfouli, M. A., Khalili, H., & Kiani, A. K. D. (2026). The role of gut microbiota in the neurobiology and treatment of Alzheimer’s disease. General physiology and biophysics, 45(02), 129-151. https://doi.org/10.4149/gpb_2025042

Vancouver

Rashidi SK, Dezfouli MA, Khalili H, Kiani AKD. The role of gut microbiota in the neurobiology and treatment of Alzheimer’s disease. General physiology and biophysics. 2026;45(02):129-151. doi:10.4149/gpb_2025042

BibTeX
@article{Rashidi2026,
  author = {Rashidi, Seyed Khalil and Dezfouli, Mitra Ansari and Khalili, Hamidreza and Kiani, Ali Kiani Deh},
  title = {The role of gut microbiota in the neurobiology and treatment of Alzheimer’s disease},
  journal = {General physiology and biophysics},
  year = {2026},
  volume = {45},
  number = {02},
  pages = {129--151},
  doi = {10.4149/gpb_2025042}
}
Kostenlos starten →